Developmental toxicity testing: Protecting future generations?

Alternatives to Laboratory Animals

Volumn 36, Issue 6, 2008, Pages 718-721

  Bailey, Jarrod ^a  

^a PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE   (United States)

Author keywords

Animal testing; Birth defects; Developmental toxicity; Teratology; Toxicity testing

Indexed keywords

CHEMICAL AGENT; TERATOGENIC AGENT;

ANIMAL USE; DATA BASE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; NONHUMAN; NOTE; PREDICTION; PRIORITY JOURNAL; RABBIT; RELIABILITY; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; TERATOGEN TESTING; TERATOGENICITY; TOXICITY TESTING;

ANIMALIA;

EID: 59849123600     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290803600618     Document Type: Note

References (15)

1. Moxon, M. (2008). Developmental and reproductive toxicity testing: a potted history. Lab Animal Europe 8(3), 3.
2. Bailey, J., Knight, A. &Balcombe, J. (2005). The future of teratology research is in vitro. Biogenic Amines - Stress &Neuroprotection 19, 97-145. Available at: http://www.curedisease.net/reports/teratology. pdf (Accessed 14.07.08).
3. Anon. (1980). United States Food and Drug Administration. Caffeine: deletion of GRAS status, proposed declaration that no prior sanction exists, and use on an intern basis pending additional study. Federal Register 45, 69,817.
4. Schardein, J.L. (1993). Chemically Induced Birth Defects, 902pp. New York, NY, USA: Marcel Dekker.
5. Anon. (2006). European Parliament Memo. Q &A on the new chemicals policy, REACH. MEMO/06/488, 16pp. Brussels, Belgium: European Parliament. Available at: http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/06/ 488 (Accessed 12.11.08).
6. Kotwani, A., Mehta, V.L. &Iyengar, B. (1995). Aspirin by virtue of its acidic property may act as teratogen in early chick embryo. Indian Journal of Physiology &Pharmacology 39, 131-134.
7. Anon. (2008). ToxCast™ Program: Predicting Hazard, Characterizing Toxicity Pathways, and Prioritizing the Toxicity Testing of Environmental Chemicals. Research Triangle Park, NC, USA: National Centre for Computational Toxicology, EPAS. Available at: http://www.epa.gov/comptox/ toxcast/index, html (Accessed 08.10.08).
8. Genschow, E., Scholz, G., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S., Becker, K. &Spielmann, H. (2000). Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitro Molecular Toxicology 13, 51-66.
9. Genschow, E., Scholz, G., Brown, N.A., Piersma, A.H., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S. &Spielmann, H. (1999). Development of prediction models for three in vitro embryotoxicity tests which were evaluated in an ECVAM validation study. ALTEX 16, 73-83.
10. Scholz, G., Pohl, I., Genschow, E., Klemm, M. &Spielmann, H. (1999). Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells, Tissues, Organs 165, 203-211.
11. Scholz, G., Genschow, E., Pohl, I., Bremer, S., Paparella, M., Raabe, H., Southee, J. &Spielmann, H. (1999). Prevalidation of the Embryonic Stem Cell Test (EST) - A new in vitro embryotoxicity test. Toxicology in Vitro 13, 675-681.
12. Spielmann, H., Pohl, I., Döring, B., Liebsch, M. &Moldenhauer, F. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicology 10, 119-127.
13. Adler, S., Pellizzer, C, Hareng, L., Hartung, T. &Bremer, S. (2008). First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicology in Vitro 22, 200-211.
14. Adler, S., Lindqvist, J., Uddenberg, K., Hyllner, J. &Strehl, R. (2008). Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells. ATLA 36, 129-140.
15. Polifka, J.E. &Friedman, J.M. (1999). Clinical teratology: identifying teratogenic risks in humans. Clinical Genetics 56, 409-420.